PharmaCross

{
  "events": [
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Philippe Peeters",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Heist-op-den-Berg",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2025-08-08",
    "filing_date": "2025-07-31",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2025-07-11",
    "unanimous": true,
    "under_authorized_capital": false,
    "underlying_resolution_date": "2025-05-16"
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0888.580.475",
    "name_full": "PharmaCross",
    "legal_form": "besloten vennootschap",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "splitsingsvoorstel",
    "verslag van het bestuursorgaan",
    "controleverslag van de bedrijfsrevisor",
    "jaarrekeningen",
    "verslagen van het bestuursorgaan",
    "tussentijdse cijfers"
  ],
  "shareholders_after": [
    {
      "kbo": null,
      "pct": null,
      "kind": "org",
      "name": "SKYPHARMA LIMITED",
      "role": "aandeelhouder",
      "n_shares": 296,
      "share_class": null
    }
  ],
  "share_classes_after": []
}

{
  "stage": "proposal",
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": "Gent",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2025-05-27",
    "filing_date": "2025-05-19",
    "act_kind_objet": "Neerlegging voorstel parti\u00EBle splitsing door overneming"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2025-05-16",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "demerger_partial",
  "report_waiver": {
    "summary": "De enige bestuurder stelt voor om te verzaken aan de verslaggevingsverplichting van de bedrijfsrevisor zoals voorzien in artikel 12:62, \u00A71 WWV, wat resulteert in het herleven van de verslaggevingsverplichtingen die van toepassing zijn in het kader van een inbreng in natura.",
    "articles": [
      "12:62, \u00A71",
      "7:179 juncto 7:197"
    ]
  },
  "restructuring": {
    "parties": [
      {
        "kbo": "0473.175.601",
        "name": "EURO-MEDIC NV",
        "role": "acquiring",
        "address": "Poeldendries 49, 9850 Deinze",
        "is_foreign": false,
        "legal_form": "NV",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": "0888.580.475",
        "name": "PHARMACROSS BV",
        "role": "demerged",
        "address": "Poeldendries 49, 9850 Deinze",
        "is_foreign": false,
        "legal_form": "BV",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": null,
        "name": "SKYPHARMA LIMITED",
        "role": "recipient",
        "address": "26 Saint Laurence Street, Drogheda, Louth, A92P5VW",
        "is_foreign": true,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": "IE"
      }
    ],
    "exchange_ratio": 2.96,
    "legal_articles": [
      "12:8, 1\u00BA",
      "12:59",
      "12:62, \u00A71",
      "12:62, \u00A72",
      "7:179 juncto 7:197"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": "2025-03-31",
    "exchange_ratio_text": "8.664,40 = 2,96",
    "new_shares_issued_n": 296,
    "real_estate_included": true,
    "patrimony_description": "Een aantal activa- en passivabestanddelen van PHARMACROSS BV worden overgedragen naar EURO-MEDIC NV.",
    "equity_transferred_eur": 866439.67,
    "accounting_effective_date": "2025-01-01"
  },
  "subject_company": {
    "kbo": "0888.580.475",
    "name_full": "PHARMACROSS",
    "legal_form": "BV"
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": null,
    "org_name": "KPMG Law BV",
    "person_name": null,
    "org_rep_person_name": null
  },
  "summary_narrative": "De bestuursorganen van EURO-MEDIC NV en PHARMACROSS BV hebben besloten tot een voorstel voor een parti\u00EBle splitsing door overneming. Hierbij worden bepaalde niet-essenti\u00EBle activa van PHARMACROSS BV overgedragen aan EURO-MEDIC NV, waarbij de aandeelhouders van PHARMACROSS BV nieuwe aandelen in EURO-MEDIC NV ontvangen. PHARMACROSS BV blijft bestaan. Het voorstel wordt ter goedkeuring voorgelegd aan de buitengewone algemene vergadering van aandeelhouders.",
  "co_filed_documents": [],
  "detected_real_type": "demerger_proposal",
  "referenced_correction": null,
  "should_reroute_to_category": null
}